Changmao Biochemical Engineering Co (HKSE:00954) Total Equity: HK$591.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00954 Changmao Biochemical Engineering Co Ltd HKSE:00954
34 GF Score
Price HK$0.22
GF Value HK$0.36
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Changmao Biochemical Engineering Co Total Equity?

Changmao Biochemical Engineering Co HKSE:00954 34 Total Equity is HK$591.2 Mil as of Jun. 2026. GuruFocus rates HKSE:00954 with a GF Score™ of 34/100 and a GF Value™ of HK$0.36 (Possible Value Trap). The stock has 6 warning signs investors should review.

Changmao Biochemical Engineering Co's total equity for the quarter that ended in Jun. 2026 was HK$591.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Changmao Biochemical Engineering Co Total Equity Historical Data

* Premium members only.

The historical data trend for Changmao Biochemical Engineering Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Changmao Biochemical Engineering Co Total Equity Chart

Changmao Biochemical Engineering Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 854.10 869.80 712.69 622.82 570.23

Changmao Biochemical Engineering Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 681.47 622.82 609.22 570.23 591.17
HKSE:00954
34GF Score
Changmao Biochemical Engineering Co Ltd HKSE:00954
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Changmao Biochemical Engineering Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Changmao Biochemical Engineering Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1303.272-733.047
=570.2

Changmao Biochemical Engineering Co's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=1314.738-723.57
=591.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$591.2 Mil mean?
Changmao Biochemical Engineering Co (HKSE:00954) has a Total Equity of HK$591.2 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Changmao Biochemical Engineering Co and its competitors.
Is Changmao Biochemical Engineering Co's Total Equity too high?
Changmao Biochemical Engineering Co's current Total Equity is HK$591.2 Mil. Overall, Changmao Biochemical Engineering Co has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Changmao Biochemical Engineering Co's Total Equity compare to LIN and SHW?
Changmao Biochemical Engineering Co's Total Equity of HK$591.2 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Changmao Biochemical Engineering Co and its competitors. Changmao Biochemical Engineering Co's current Total Equity is HK$591.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changmao Biochemical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Changmao Biochemical Engineering Co (HKSE:00954) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.36, compared to a current price of HK$0.22 — trading 39.4% below its estimated fair value. The current Total Equity is HK$591.2 Mil. Changmao Biochemical Engineering Co's overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Changmao Biochemical Engineering Co (HKSE:00954), the current Total Equity is HK$591.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Changmao Biochemical Engineering Co (HKSE:00954) Overvalued in 2026?

Based on GuruFocus' analysis, Changmao Biochemical Engineering Co stock appears to be undervalued. The current stock price of HK$0.22 is trading 39.4% below its estimated GF Value™ of HK$0.36. GuruFocus considers Changmao Biochemical Engineering Co to be Possible Value Trap.

Key valuation signals for HKSE:00954:

  • Total Equity: HK$591.2 Mil
  • GF Value™: HK$0.36 vs. price of HK$0.22 (39.4% below fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the HKSE:00954 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Changmao Biochemical Engineering Co Business Description

Address No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
34GF Score

Get the complete analysis for HKSE:00954

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.22
Price
HK$0.36
GF Value